Meralgia Paresthetica Clinical Trial
Official title:
6-month Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia
Meralgia paresthetica (MP) is one of the most common peripheral entrapment neuropathies of the lower limbs. It is characterized by paresthesia, pain, tingling, numbness, hypersensitivity, or other abnormal skin sensations on the anterolateral aspect of the thigh. The condition results from compression of the lateral femoral cutaneous nerve (LFCN) along its course, often occurring as the nerve exits the pelvis.The injection of 5% dextrose (D5W) under ultrasound guidance is a novel treatment method for peripheral nerve entrapment. However, there is limited evidence about the efficacy of this method for patients with MP. The investigators found D5W was more safe and effective than corticosteroids for patients with MP. Thus, this study aimed to evaluate the 6-month efficacy of ultrasound-guided injection of D5W for MP patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04747119 -
Effect of MET on Meralgia Paraesthesia Postpartum "Muscle Energy Technique"
|
N/A | |
| Completed |
NCT06187883 -
Pulsed Radiofrequency of Lateral Femoral Cutaneous Nerve
|
||
| Completed |
NCT02577510 -
Comparing Ways to Freeze the Nerve That Provides Thigh Sensation
|
Phase 3 | |
| Withdrawn |
NCT04046406 -
Pelvic Pain Treated With MR-guided Cryoanalgesia
|
N/A | |
| Recruiting |
NCT05893732 -
HILT for Meralgia Paresthetica: A Randomized Controlled Trial
|
N/A | |
| Completed |
NCT04004052 -
Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica
|
N/A | |
| Completed |
NCT04499911 -
Efficacy of Neural Prolotherapy in Treatment of Meralgia Paresthetica
|
N/A |